$0.3113
-0.24-43.3%
Last update: Nov 11, 1:35 PM
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics, Inc.
ZVSAOTCEM
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics fell 99.9% from $0.15 to $0.00, behind the S&P 500's +11.2%. Its worst day was Oct 19 (−99.6%), and its low came Nov 5 at $0.00.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-2.56 was reported on $0.00 revenue.
+3.7% · S&P 500 −1.5%
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics closed at its highest level of the year, 80.0% above where the year started.
Story events cover the past 12 months · Times ET
+3.8% · S&P 500 −0.6%
EPS of $-0.22 was reported on $0.00 revenue.
+11.0% · S&P 500 +0.8%
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics shares rose 400.0%, while the S&P 500 rose 0.3%.
+400.0% · S&P 500 +0.3%
ZYVERSA THERAPEUTICS INC by ZyVersa Therapeutics closed at its lowest level of the year, 99.9% below where the year started.
−90.0% · S&P 500 −4.4%
Where it ended: a close of $0.00 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 23, 2026.
Nothing in the past 12 months.
All ZVSA analyst actionsNothing in the past 12 months.
All ZVSA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ZVSA and SPY from Benzinga historical bars. Not investment advice.
